A b s t r a c t
Our purpose was to develop and evaluate isolation and enrichment of fetal erythroblasts and a nested polymerase chain reaction (PCR) approach using fetal erythroblasts for detecting the β-globin gene mutations for a noninvasive prenatal diagnosis of hemoglobinopathies. Maternal blood at different periods of gestation was layered on a Percoll density gradient for enrichment of fetal nucleated RBCs (NRBCs). A combination of 3 monoclonal antibodies (CD45-peridinin chlorophyll protein, glycophorin A-phycoerythrin, and anti-hemoglobin F-fluorescein isothiocyanate) was used for flow cytometric sorting of fetal NRBCs from enriched cells. Different nested PCRbased approaches were used for identification of fetal mutations.
Owing to heterogeneity of β-thalassemia mutations in the population of India, we had to screen for 12 mutations A long sought goal of scientists has been to develop prenatal diagnostic procedures that do not endanger the fetus. Until the 1950s, genetic counseling was the only option offered to couples with a family history of inherited disorders. During the past few decades, the invasive approaches for fetal tissue and blood sampling like amniocentesis, chorionic villus sampling (CVS), and cordocentesis have improved tremendously. It has been estimated that about 12,000 infants are born each year with a severe hemoglobinopathy in India. 1 The current methods of CVS and DNA analysis in the first trimester of pregnancy and cordocentesis and fetal blood analysis in the second trimester of pregnancy for prenatal diagnosis of hemoglobinopathies are well established and are accurate; however, they are not available to people who reside in rural areas or small towns. 2, 3 Also, these techniques involve a small but significant risk of fetal loss. The isolation of fetal erythroblasts from maternal blood is a noninvasive, risk-free strategy, which helps in obtaining a fetal sample from maternal peripheral venous blood during pregnancy.
Because fetal erythroblasts in the maternal circulation are rare, they are first enriched by the use of Percoll gradients 4 or Ficoll gradients. 5 To obtain fetal cells, various strategies have been devised, such as the use of monoclonal antibodies to sort the cells by fluorescent activated cell sorting (FACS), 6 magnetic activated cell sorting, 7 and charge flow separation. 8 We describe a simple nested polymerase chain reaction (PCR) approach after the isolation of nucleated RBCs (NRBCs) by FACS for noninvasive prenatal diagnosis in pregnancies at risk for hemoglobinopathies.
Materials and Methods
This study included 100 couples who were carriers of different mutations causing β-thalassemia, sickle cell anemia, and hemoglobin (Hb) E-β-thalassemia. These couples were referred to our institute for prenatal diagnosis by CVS or cordocentesis. Informed consent was obtained as required by the ethical committee of our institute. Initially, 20 mL of peripheral venous blood was obtained from the mother in EDTA. In addition, 10 mL of blood from the father and any previously affected child was obtained. After blood sample collection, the couples were referred for the invasive procedure for fetal tissue or blood sampling depending on the gestational age of the fetus. The gestational age ranged from 9 to 22 weeks when the invasive sampling procedures were done.
Enrichment of Fetal Cells
For enrichment, 7 mL of peripheral venous blood from the mother was diluted 1:1 with normal saline (0.9% NaCl) and gently layered onto a Percoll discontinuous density gradient (Sigma, St Louis, MO). The sample was then centrifuged at 3,000 rpm for 30 minutes. The cell layer at the interface of 1.075 g/mL and 1.085 g/mL Percoll gradients was collected and washed with phosphate-buffered saline. 4, 9 
Isolation of Fetal NRBCs Using Flow Cytometry
The cells were permeabilized using glutaraldehyde. 10 Next, 100 µL of the cell suspension was stained with CD45-peridinin chlorophyll protein, glycophorin A tagged with phycoerythrin, and anti-fetal hemoglobin (HbF) tagged with fluorescein isothiocyanate (Becton Dickinson, San Diego, CA). Fetal cell sorting was performed on a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA) by first gating the CD45-cells and sorting the dual-positive cells, ie, HbFand glycophorin A-positive cells in the gated population. The sorted cells were collected, and DNA was extracted using the Qiagen Mini Blood Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. Fetal DNA was collected in 50 µL of the AE buffer provided in the kit.
Genetic Analysis
For genetic analysis, 10 mL of the blood from the couple and any affected child was used for the isolation of DNA by the phenol chloroform method. 11 The fetal DNA from CVS or the fetal blood sample was also extracted using the Qiagen Mini Blood Kit and was collected in 50 µL of the AE buffer provided.
The mutations in the samples were detected by using a stepwise approach. In the first step, 6 common Indian mutations causing β-thalassemia were screened for by covalent reverse dot blot hybridization using a single PCR with the biotin-labeled primers China 1 and PCO 6 (Sigma Genosys, Bangalore, India) and a hybridization step as described earlier 3 : intervening sequence (IVS) 1-5 (G→C), IVS 1-1 (G→T), codon (Cd) 8/9 (+G), Cd 41/42 (-CTTT), Cd 15 (G→A), and Cd 30 (G→C) along with HbS and HbE. If these mutations were absent, screening for other uncommon Indian β-thalassemia mutations was done by amplification refractory mutation system (ARMS) using allele-specific primers. 12 The 619-base-pair (bp) deletion was detected by PCR across the breakpoints of the deletion and electrophoresis on a 2% agarose gel.
Nested PCR-Based Approach
Depending on the mutations of the parents, the strategy for characterization of the mutations in the fetal DNA isolated from the maternal blood was planned. A 739-bp region of the β-globin gene from the promoter region up to IVS 2 was amplified. The nested PCR was based on ARMS. A 1:100 dilution of the first PCR product was used as the template for the nested PCR reaction. In the example shown in ❚Figure 1A❚, both parents were carriers of Cd 5 (-CT). In the nested ARMS PCR, a 690-bp fragment corresponds to the internal control primers (CM23 and C2) and a 167-bp region (primers CM23 and normal or mutant primers for Cd 5) to the normal or mutant-specific fragments.
The 619-bp deletion was detected by amplification of a 1.2-kb fragment from IVS 2 to the 39 untranslated region of the β-globin gene using primers D1 and HinfI/β-reverse ❚Figure 1B❚. This PCR product was used as the template for the nested PCR to amplify an 860-bp fragment if the mutation was absent and a 241-bp fragment when the 619-bp deletion was present.
In 95 cases, a 739-bp fragment of the fetal DNA was amplified by using 10 µL of template DNA and primers China 1 and PCO 6. A 1: 100 µL dilution of this PCR product was then used as the template for the nested PCR based on ARMS. The 25-µL reaction mixture contained 10× PCR buffer containing 15 mmol/L of magnesium chloride, 1.25 mmol/L of deoxynucleoside triphosphate (dNTP) mix, spermidine (1 mol/L solution; Sigma), and Taq polymerase (5 U/µL). This PCR strategy uses a pair of internal control primers (C2 and CM23) and 10 pmol/µL of allele-specific normal and mutant primers. The PCR conditions were set at 94°C for 1 minute, 59°C for 1 minute, and 72°C for 1 minute 30 seconds for 25 cycles.
For 13 cases with the 619-bp deletion, the 25-µL PCR mix contained 10× PCR buffer containing 15 mmol/L of magnesium chloride, 1.25 mmol/L of dNTP mix, spermidine (1 mol/L solution), and Taq polymerase (5 U/µL; Bioron, Ludwigshafen, Germany); 10 µL of fetal DNA; and primers D1 and HinfI/β-reverse. The PCR program involved 30 cycles at 94°C for 1 minute, 50°C for 1 minute, and 72°C for 1 minute 30 seconds. A 1:100 µL dilution of this PCR product was used for the nested PCR using primers 2a and 2b, and the PCR protocol included 94°C for 1 minute, 65°C for 1 minute, and 72°C for 1 minute 30 seconds for 25 cycles.
All samples were run on a 2% agarose gel along with marker VIII (Roche, Indianapolis, IN) and stained with ethidium bromide.
To rule out the problem of allele-specific amplification, we tried an alternative nested PCR method also in cases in which the common mutations were present. An 857-bp fragment from the promoter of the β-globin gene to the middle of IVS 2 was amplified using primers Hemat 1 and Hemat 2. The 50-µL reaction mixture contained 10× PCR buffer containing 2.5 mmol/L of magnesium chloride, 25 mmol/L of dNTP mix, and Taq polymerase (5 U/µL); 10 µL of fetal DNA; and 10 pmol/µL of primers Hemat 1 and Hemat 2. The PCR program included 30 cycles at 94°C for 1 minute, 56°C for 1 minute, and 72°C for 1 minute. Then 10 µL of this PCR product was used for the nested PCR by the covalent reverse dot blot hybridization PCR protocol described earlier using the biotin-labeled primers China 1 and PCO 6 to amplify a 739-bp fragment. The mutations in the samples were detected by reverse dot blot hybridization. 3 
Analysis of Variable Number of Tandem Repeats
To address the problem of the possibility of maternal contamination in the fetal cells, we developed a nested PCR method for variable number of tandem repeats (VNTR) analysis using the apolipoprotein B (ApoB) and IgJ H genes. The ApoB lipoprotein gene was amplified using primers ApoB1 and ApoB2. The 50-µL reaction mixture contained 10× PCR A B ❚Figure 1❚ A, General strategy for detection of β-globin gene mutations by nested polymerase chain reaction (PCR). B, The strategy for detecting the 619-base-pair (bp) deletion. for information on the primers, see Table 1 . Cd, codon; IVS, intervening sequence.
buffer containing 2.5 mmol/L of magnesium chloride, 25 mmol/L of dNTP mix, and Taq polymerase (5 U/µL); 10 µL of fetal DNA; and 10 pmol/µL of primers ApoB1 and ApoB2. The PCR program was set at 94°C for 5 minutes, 94°C for 1 minute, 56°C for 1 minute, and 72°C for 1 minute for 30 cycles. Then, 2 µL of this PCR product was used for the nested PCR using primers 39 ApoB and 59 ApoB. The same PCR conditions were used as those described in the preceding sentence; however, the PCR cycles were reduced to 25.
The 50-µL reaction mixture for amplification of the IgJ H gene contained 10× PCR buffer containing 2.5 mmol/L of magnesium chloride, 25 mmol/L of dNTP mix, and Taq polymerase (5 U/µL); 10 µL of fetal DNA; and 15 pmol/µL of primers IgJ H reverse and 59 IgJ H . The PCR program was set at 94°C for 5 minutes, 68°C for 3 minutes, 94°C for 2 minutes, 68°C for 6 minutes, and 68°C for 10 minutes for 30 cycles. Then 5 µL of this PCR product was used for a seminested PCR using primers 39 IgJ H and 59 IgJ H . The same PCR conditions were used as that described in the preceding sentence; however, the PCR cycles were reduced to 25.
The PCR products were then loaded on a 3% agarose gel along with marker XIII (Roche) and stained with ethidium bromide.
The sequences of the primers are shown in ❚Table 1❚.
Results
The 7 mL maternal blood layered on a Percoll discontinuous gradient gave a clear distinct band at the interface. We made use of a single sort strategy to isolate the fetal NRBCs, and the number sorted was enumerated using the sort counter of the flow cytometer.
The gestational age ranged from 9 to 22 weeks with 83 cases in the first trimester and 17 cases in the second trimester. The number of NRBCs isolated ranged from 12 to 786 in the first trimester and 28 to 339 in the second trimester. These results indicate that fetal NRBCs could be isolated from the maternal blood starting from the ninth week of gestation. With the increase in the gestational age from 9 to 15 weeks, we observed an increase in the number of NRBCs, but after 15 weeks, there was a fall in the number of fetal NRBCs.
The results of noninvasive diagnosis using the nested PCR approach were compared with results obtained by the traditional invasive procedures ❚Table 2❚. To avoid bias, the noninvasive and invasive diagnoses were done independently by 2 investigators (E.D. and P.M.S.). There were 12 different parental mutations to be screened for. In 36 cases, the mutations in the mother and father were different.
The diagnosis, ie, the ability to determine the fetal genotype, was possible in 84 (84.0%) of 100 cases. In 10 cases, the diagnosis by the noninvasive approach was incorrect, possibly owing to maternal contamination, whereas in 6 cases, the diagnosis was incorrect possibly owing to the nonamplification of alleles. ❚Image 1❚ shows the results of noninvasive diagnosis in a fetus at risk for sickle cell disease. The absence of the sickle mutation is seen in the CVS sample (lanes 7 and 8) and in the fetal cells isolated from maternal blood (lanes 9 and 10).
Of the 36 cases in which the maternal and paternal mutations were different, we were able to detect the presence of the paternal mutation in 9 fetuses and the absence of both parental mutations in 9 fetuses correctly, indicating the absence of maternal contamination.
We were also able to detect the presence of fetal mutations by using the alternative nested PCR approach and reverse dot TCA TTC GTC TGT TTC CCA TT  CM23  ACC TCA CCC TGT GGA GCC AC  C2  GGT TAA GTT CAT GTC ATA GG  D1 CCT blot hybridization in a few cases ❚Image 2❚. In this family, the mother was heterozygous for the Cd 8/9 (+G) mutation, and the father was heterozygous for the IVS 1-5 (G→C) mutation. By CVS and DNA analysis, we detected that the fetus had inherited the IVS 1-5 (G→C) mutation. Identical results were obtained from the fetal cells isolated from the maternal blood by the nested PCR approach based on ARMS (lanes 8 and 9 in Images 2A and 2B) and from the nested PCR and reverse dot blot hybridization (Image 2C, strip 4). VNTR analysis using the ApoB polymorphism was done in 12 families who were informative for this polymorphism; no maternal contamination was detected in the noninvasively isolated fetal cells. ❚Image 3❚ shows the ApoB polymorphism analysis in a family. The noninvasively isolated fetal sample (lane 4) is homozygous for the 571-bp genotype, similar to the CVS sample (lane 3), whereas the mother's genotype is 571-bp/631-bp (lane 1) and the father's is 571-bp/691-bp (lane 2). Thus, there was no maternal contamination. The sample sorted allowed for the correct identification of the fetal genotype. We used the IgJ H polymorphism in 4 families and were able to detect the presence of maternal contamination in 1 sample. ❚Image 4❚ shows the analysis of the polymorphism. The mother is heterozygous for the 721-bp/811-bp genotype (lane 2) and the father is homozygous for the 571-bp genotype (lane 3). It is evident in lane 4, which is the fetal DNA sample showing 3 bands, 2 corresponding to those of the mother and 1 band of the father, that maternal contamination is present. The other 3 families that were informative for the polymorphism did not show any maternal contamination.
Discussion
We were successful in isolating an adequate number of fetal NRBCs from 7 mL of maternal blood by use of a simple density gradient centrifugation and staining with specific monoclonal antibodies, with an accuracy of 84.0% in diagnosis of fetal mutations. It is now well established that fetal NRBCs in the maternal circulation are ideal candidates for noninvasive prenatal diagnosis. The stability of the NRBCs up to 180 hours in stored samples highlighted the effectiveness of choosing fetal erythroblasts as the ideal candidates for noninvasive diagnosis. 13 In 5 cases, we were able to isolate Most of the PCR defined methods reported earlier were restricted in their application only to sex-linked disorders and to pregnancies with male fetuses. Noninvasive prenatal diagnosis could be used to its maximum if fetal cells from the maternal circulation are used for genetic analysis of autosomal disorders. 4, 17, 18 Camaschella et al 19 took the first step in the noninvasive prenatal diagnosis of a single gene disorder when they successfully performed prenatal diagnosis of Hb Lepore Boston disease. They were able to give an accurate diagnosis in 2 of 3 cases when the mother was a carrier of β-thalassemia and the father was a carrier of Hb Lepore Boston. Their diagnoses were concordant with those obtained by CVS and DNA analysis.
Cheung et al 20 described an enrichment approach by magnetic activated cell sorting followed by pickup of fetal cells by microdissection, and they were able to identify the fetal genotypes in 2 fetuses at risk for sickle cell anemia and β-thalassemia. Di Naro et al 21 enhanced the use of Percoll as a density gradient by incorporating Gastrografin. By micromanipulation and single cell PCR, they characterized fetal genotypes in 4 cases at risk for β-thalassemia mutations in the Mediterranean region. 21 Our study is the first large study on the detection of several different β-globin gene mutations causing hemoglobinopathies using fetal NRBCs from maternal blood in 100 cases. We devised a simple nested PCR approach and were able to give the correct diagnosis in 84 cases. We have successfully been able to show the presence of the paternal mutation in 9 cases and absence of both parental mutations in 9 cases, indicating the usefulness of FACS for isolation. However, there were 10 cases in which we encountered maternal contamination, indicating the drawback of this sorting procedure in which a few maternal cells could also have been sorted along with the fetal NRBCs.
To tackle the issue of detection of maternal contamination, particularly when the parental mutations are identical, we subsequently developed a VNTR-based analysis of the ApoB and IgJ H gene polymorphisms that was used in 16 cases. By using this approach, we were able to show that the DNA isolated from the NRBCs was fetal in 15 cases, and we were also able to detect maternal contamination in 1 case. By using additional VNTR and short tandem repeat markers, the problem of maternal contamination in the isolated fetal NRBCs could be eliminated.
Owing to the heterogeneity of β-thalassemia mutations in the Indian population and the presence of abnormal hemoglobins like HbS and HbE, we had to screen for 12 different mutations in these 100 families. In view of the possibility of allele-specific amplification in the ARMS approach, we used a different set of primers for the nested PCR along with covalent reverse dot blot hybridization to detect the mutations in a few cases. We obtained comparable results, eliminating the fetal NRBCs even after 48 hours of collection and storage of the sample at 4°C. Thus, samples could be collected from pregnant women at risk of a severe hemoglobin disorder in rural areas where facilities for invasive procedures are not available and the women are unwilling to come to large cities for diagnosis.
The effectiveness in the FACS strategy was in the choice of the monoclonal antibodies. We used a positive and a negative selection to isolate NRBCs. The negative selection was done by using CD45 peridinin chlorophyll protein, by which we could eliminate most of the maternal cells. The positive selection was achieved by sorting the dual-positive cells for glycophorin A-phycoerythrin and anti-HbF-fluorescein isothiocyanate. We had confirmed the presence of dual positive NRBCs in the postsorted sample by confocal microscopy. 9 The use of antibodies specific for embryonic Hb chains may also enhance the specificity.
We observed a decrease in the number of fetal cells after 18 weeks' gestation, and our results are consistent with the findings of other scientists. Thomas and Yoffey 14 reported a drastic decrease in the number of NRBCs after 12 weeks. In 1991, Bianchi et al 15 reported the absence of fetal NRBCs in women after 16 weeks' gestation. By carrying out fetal cell enrichment using FACS with the monoclonal antibodies TfR, Leu-4, and Leu-M3 and a single-copy Y chromosomal DNA sequence analysis, they were able to determine Y-specific DNA until 16 weeks following which no Y DNA sequences were detected. 15 Choolani et al 16 demonstrated that the frequency of morphologically primitive erythroblasts fell progressively across the first trimester and reached negligible levels by 14 weeks. Our study showed that the ideal gestation age for recovery of fetal cells would be between 11 and 15 weeks. problem of allele-specific amplification in these cases. This emphasizes the need for confirming the results by using 2 different approaches in every case. Although recent studies are directed to the use of cell-free fetal DNA in maternal plasma and real-time PCR-based methods for noninvasive diagnosis, the limitations are that plasma samples have to be processed immediately and facilities for real-time PCR may not be easily available in many developing countries. Thus, using fetal NRBCs is a valid alternative that will allow couples at risk of having a child with a severe hemoglobinopathy even in remote areas to obtain a diagnosis without endangering the fetus.
